On September 15, Axon Enterprise, Inc. fell 7.13% in regular trading, trading at $450.735 per share, with turnover of approximately $49.20 million. The decline was triggered by the company's announcement of a planned $1 billion offering of 0% convertible senior notes due 2031.

Axon Enterprise, Inc. disclosed that it intends to conduct a registered public offering of $1 billion in zero-coupon convertible senior notes maturing on September 15, 2031. Underwriters will be granted an over-allotment option of up to an additional $150 million. The offering is jointly led by Goldman Sachs, Morgan Stanley, JPMorgan, RBC Capital Markets, and Citigroup. The company plans to use part of the net proceeds to fund capped call transactions designed to mitigate potential dilution from future conversions, with the remainder earmarked for general corporate purposes including growth investments and potential acquisitions. Separately, SEC filings revealed Axon increased its revolving credit facility by $150 million to $500 million.

While the convertible notes carry no regular interest, the potential dilutive impact on existing shareholders weighed on sentiment. Notably, Axon reported strong Q2 results in August, with revenue rising 35% year-over-year to $904.4 million and full-year revenue growth guidance raised to 32%-34%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)